공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

원격 환자 모니터링 시스템 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년)

Remote Patient Monitoring Systems Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 03월 상품 코드 353840
페이지 정보 영문
가격
US $ 4,250 ₩ 4,788,000 PDF (Single User License)
US $ 4,750 ₩ 5,352,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 6,760,000 PDF (Site License)
US $ 7,500 ₩ 8,451,000 PDF (Corporate License)


원격 환자 모니터링 시스템 시장 : 성장, 동향, COVID-19의 영향, 예측(2021-2026년) Remote Patient Monitoring Systems Market - Growth, Trends, Covid-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 03월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

만성질환 환자 증가, 고령자 증가, 가정간호용 모니터링 기기 수요 등이 시장 성장 주요인입니다.

세계의 원격 환자 모니터링 시스템(Remote Patient Monitoring Systems) 시장을 조사했으며, 시장 개요, 기기 유형·용도·최종사용자·지역별 시장 규모 추이와 예측, 시장 성장요인 및 저해요인 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 조사 성과
  • 조사의 전제조건
  • 조사 범위

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 성장요인
    • 생활습관 변화에 기인한 만성질환 이환률 상승
    • 고령자 인구 증가
    • 가정용 모니터링 기기 수요 증가
  • 시장 성장 저해요인
    • 헬스케어 전문가의 반감
    • 엄격한 규제 프레임워크
    • 적절한 상환제도 부재
  • Five Forces 분석
    • 구매자의 협상력
    • 공급기업의 협상력
    • 신규 진출기업의 위협
    • 대체품의 위협
    • 경쟁 기업간 경쟁 관계

제5장 원격 환자 모니터링 시스템 시장 : 부문별

  • 기기 유형별
    • 심장 모니터
    • 호흡 모니터
    • 혈액 모니터
    • 다항목 모니터
    • 기타
  • 용도별
    • 암치료
    • 심혈관질환
    • 당뇨병 치료
    • 수면장애
    • 체중 관리 및 피트니스 모니터링
    • 기타
  • 최종사용자별
    • 가정간호
    • 진료소
    • 병원
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제6장 경쟁 구도

  • 기업 개요
    • Abbott Laboratories
    • Aerotel Medical Systems
    • AMD Global Telemedicine
    • Baxter
    • Boston Scientific
    • Covidien
    • GE Healthcare
    • Honeywell
    • Masimo Corporation
    • Medtronic
    • Omron
    • Proteus Digital Health

제7장 시장 기회 및 향후 동향

LSH 19.07.01

The Remote Patient Monitoring Systems Market registered a market size of USD 1,031.67 million in 2020 and is expected to reach 1,679.95 million by 2026, registering a CAGR of 8.51 % during the forecast period.

Globally, the COVID-19 pandemic showed enormous pressure on hospitals and healthcare systems that were understaffed and overworked. Remote Patient Monitoring technology helped patients to keep safe within the home while reducing stress on hospitals, emergency rooms, and the front-line health care workers during the pandemic which shows the positive impact on the market.

The major factors driving the market growth include the rising burden of chronic diseases due to lifestyle changes, the rising geriatric population, and the growing demand for home-based monitoring devices. Remote patient monitoring is ambulatory healthcare that allows patients to use a mobile medical device to accomplish a routine test and guide the test data to a healthcare expert in real-time. Globally, the rising chronic disease population along with the increasing aging population increasing demand for home-based monitoring devices which is boosting the market growth. For instance, according to a research article by Kimberly D. Miller et al., published in Cancer Journal for Clinicians 2019, the three most prevalent cancers in 2019 were prostate cancer (3,650,030), colon and rectal cancers (776,120), and melanoma of the skin (684,470) among males, and breast cancer (3,861,520), uterine corpus (807,860), and colon and rectal cancers (768,650) among females.​

Worldwide, the use of home-based devices is increasing as these are simple, and can be used by all age groups. Moreover, home-based devices is mainly utilized by geriatric population as this population are more prone to chronic conditions. For instance, according to the World Population Ageing 2019 report, globally, in 2019, there were around 703 million people aged 65 years or over. This number is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019 and this number is projected to rise further to 16% in 2050.

In addition, these devices are compact and portable and the patients can wear it all the time without unease. These devices also ensure that the patient's condition is monitored all the time.

Despite, resistance from the healthcare industry professionals toward the adoption of the monitoring systems, lack of proper reimbursement policies in developed markets along with stringent regulatory framework are the factors impeding market growth.

Key Market Trends

Multi Parameter Monitors Segment is Expected to Show Significant Growth over the Forecast Period

Multi-parameter monitors are devices that monitor various parameters, such as arterial blood pressure, heart rate, body and skin temperature, oximetry, and capnography, with a single device. These devices have become popular as they are small, portable, and user-friendly.

Many people with COVID-19 have low oxygen levels which can be an early warning sign that people need medical care. The impact of COVID-19 on the multi-parameter monitors segment was positive because this monitoring device helped patients to monitor oxygen levels by using oximeters which shows positive impact on the market. For instance, according to a research article by Ingrid Torjesen published in BMJ Journal October 2020, during the COVID-19 pandemic NHS England have purchased around 200,000 pulse oximeters for home scheme in monitoring oxygen saturation levels for people who don't need immediate hospital attention.

These multi-parameter remote monitoring devices are used not only by medical professionals but also by the health-conscious population, as sleep and activity monitors fall in these categories. The increased death rate due to chronic diseases across the developed countries, such as the United States, and the developing countries, raises awareness among the people to use early and easy monitoring devices.

As per the American Heart Association, 2020 Heart Disease and Stroke Statistical Update Fact Sheet, globally, in 2017, an estimated 126.5 million people had ischemic heart disease, and it was more prevalent in males than in females (68.5 and 57.9 million people, respectively). Furthermore, high capability to monitor various chronic conditions, such as cardiovascular conditions, is expected to fuel the demand for remote patient monitoring systems.

The market players adopted various strategies such as product launches, product developments, collaborations and expansions to increase market revenue. For instance, in December 2019, Masimo Corporation received United States FDA approval for the Neonatal RD SET Pulse Oximetry Sensors.

Therefore, rising focus on a healthy lifestyle, increasing concern for the constant monitoring of health parameters of patients and the growing trend of self-monitoring and preventive medicine are expected to drive the growth of the overall market.

North America is Expected to be the Major Contributor to the Market over the Forecast Period

The major factors driving the market growth include growing burden of chronic diseases, increasing geriatric population, demand for wireless and portable systems coupled with the presence of sophisticated reimbursement structure.

The COVID-19 pandemic has changed the landscape of healthcare delivery in United States, with a new shift towards remote patient monitoring. For instance, According to a research article by Darren Roblyer published in Journal of Biomedical Optics October 2020, industrial and academic research projects use these devices to predict a variety of health outcomes and disease states, including surgical recovery, overall mortality, mental health, heart conditions, and others diseases states. Adding to that, in April 2020 during COVID-19 pandemic in the United States, telehealth claims accounted for 20% of submitted medical and dental claims in the northeastern United States.

In addition, there is a growing trend of shifting treatment from hospitals to homes, in order to reduce hospital bills. The increasing economic burden on hospitals due to a large number of inpatients resulting in the increased adoption of remote patient monitoring devices in the United States. Moreover, patients prefer home healthcare due to privacy, cost-effectiveness, and convenience which shows positive impact on market growth.

The market players in the country adopted various strategies such as product launches, product developments, collaborations and expansions to increase market revenue. For instance, in 2020, Masimo Corporation acquired the connected care business from NantHealth, which helped strengthen its position in the connected care market in United States. Therefore, considering above mentioned factors it is expected to show growth over the forecast period.

Competitive Landscape

The remote patient monitoring market is moderately fragmented. Various medical device manufacturers are operating in the market, along with several specialized remote patient monitoring equipment manufacturers. The industry is highly competitive, and there is a growing trend of partnerships and agreements between the industry participants and other medical device manufacturers, in order to incorporate remote patient monitoring functionalities in their devices. Some of the key market players include Abbott Laboratories, Aerotel Medical Systems, AMD Global Telemedicine, Baxter International Inc., Boston Scientific Corporation, GE Healthcare, Masimo Corporation, Medtronic PLC, F. Hoffmann-La Roche AG, and Omron Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Chronic Diseases Due to Lifestyle Changes and Increasing Geriatric Population
    • 4.2.2 Growing Demand for Home-based Monitoring Devices
    • 4.2.3 Technological Advancements in Remote Patient Monitoring (RPM) Devices
  • 4.3 Market Restraints
    • 4.3.1 Resistance from Healthcare Industry Professionals
    • 4.3.2 Stringent Regulatory Framework
    • 4.3.3 Lack of Proper Reimbursement
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type of Device
    • 5.1.1 Heart Monitors
    • 5.1.2 Breath Monitors
    • 5.1.3 Hematology Monitors
    • 5.1.4 Multi-parameter Monitors
    • 5.1.5 Other Types of Devices
  • 5.2 By Application
    • 5.2.1 Cancer Treatment
    • 5.2.2 Cardiovascular Diseases
    • 5.2.3 Diabetes Treatment
    • 5.2.4 Sleep Disorder
    • 5.2.5 Weight Management and Fitness Monitoring
    • 5.2.6 Other Applications
  • 5.3 By End User
    • 5.3.1 Home Care Settings
    • 5.3.2 Hospital/Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States (By Type of Device, By Application, and By End User)
      • 5.4.1.2 Canada (By Type of Device, By Application, and By End User)
      • 5.4.1.3 Mexico (By Type of Device, By Application, and By End User)
    • 5.4.2 Europe
      • 5.4.2.1 Germany (By Type of Device, By Application, and By End User)
      • 5.4.2.2 United Kingdom (By Type of Device, By Application, and By End User)
      • 5.4.2.3 France (By Type of Device, By Application, and By End User)
      • 5.4.2.4 Italy (By Type of Device, By Application, and By End User)
      • 5.4.2.5 Spain (By Type of Device, By Application, and By End User)
      • 5.4.2.6 Rest of Europe (By Type of Device, By Application, and By End User)
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China (By Type of Device, By Application, and By End User)
      • 5.4.3.2 Japan (By Type of Device, By Application, and By End User)
      • 5.4.3.3 India (By Type of Device, By Application, and By End User)
      • 5.4.3.4 Australia (By Type of Device, By Application, and By End User)
      • 5.4.3.5 South Korea (By Type of Device, By Application, and By End User)
      • 5.4.3.6 Rest of Asia-Pacific (By Type of Device, By Application, and By End User)
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC (By Type of Device, By Application, and By End User)
      • 5.4.4.2 South Africa (By Type of Device, By Application, and By End User)
      • 5.4.4.3 Rest of Middle East and Africa (By Type of Device, By Application, and By End User)
    • 5.4.5 South America
      • 5.4.5.1 Brazil (By Type of Device, By Application, and By End User)
      • 5.4.5.2 Argentina (By Type of Device, By Application, and By End User)
      • 5.4.5.3 Rest of South America (By Type of Device, By Application, and By End User)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Aerotel Medical Systems
    • 6.1.3 AMD Global Telemedicine
    • 6.1.4 Baxter International Inc.
    • 6.1.5 Boston Scientific Corporation
    • 6.1.6 GE Healthcare
    • 6.1.7 Masimo Corporation
    • 6.1.8 Medtronic PLC
    • 6.1.9 Omron Corporation
    • 6.1.10 Philips Healthcare
    • 6.1.11 OSI Systems, Inc
    • 6.1.12 Hill-Rom Holdings, Inc
    • 6.1.13 Dragerwerk AG & Co. KGaA
    • 6.1.14 Compumedics Limited
    • 6.1.15 Nihon Kohden Corporation
    • 6.1.16 F. Hoffmann-La Roche AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q